Temasek Holdings Private Ltd lifted its position in Cognex Co. (NASDAQ:CGNX) by 366.1% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 15,660 shares of the scientific and technical instruments company’s stock after purchasing an additional 12,300 shares during the quarter. Temasek Holdings Private Ltd’s holdings in Cognex were worth $1,727,000 as of its most recent SEC filing.
Several other large investors have also recently made changes to their positions in CGNX. Janney Montgomery Scott LLC raised its position in Cognex by 6.0% during the second quarter. Janney Montgomery Scott LLC now owns 9,559 shares of the scientific and technical instruments company’s stock valued at $812,000 after acquiring an additional 541 shares in the last quarter. Great West Life Assurance Co. Can raised its position in Cognex by 1.3% during the second quarter. Great West Life Assurance Co. Can now owns 51,795 shares of the scientific and technical instruments company’s stock valued at $4,395,000 after acquiring an additional 664 shares in the last quarter. CAPROCK Group Inc. purchased a new position in Cognex during the second quarter valued at approximately $220,000. Daiwa Securities Group Inc. purchased a new position in Cognex during the second quarter valued at approximately $102,000. Finally, World Asset Management Inc raised its position in Cognex by 4.3% during the second quarter. World Asset Management Inc now owns 6,244 shares of the scientific and technical instruments company’s stock valued at $530,000 after acquiring an additional 260 shares in the last quarter. Hedge funds and other institutional investors own 84.25% of the company’s stock.
Shares of Cognex Co. (NASDAQ CGNX) opened at $62.89 on Wednesday. Cognex Co. has a 1-year low of $29.04 and a 1-year high of $72.99. The company has a market capitalization of $10,963.60, a P/E ratio of 46.72 and a beta of 1.50.
Cognex (NASDAQ:CGNX) last issued its quarterly earnings data on Monday, October 30th. The scientific and technical instruments company reported $0.57 EPS for the quarter, beating the consensus estimate of $0.52 by $0.05. Cognex had a return on equity of 23.31% and a net margin of 34.77%. The company had revenue of $259.74 million for the quarter, compared to analyst estimates of $255.95 million. During the same period last year, the company earned $0.31 earnings per share. Cognex’s quarterly revenue was up 75.6% compared to the same quarter last year. research analysts anticipate that Cognex Co. will post 1.39 EPS for the current fiscal year.
The firm also recently disclosed a quarterly dividend, which was paid on Friday, December 1st. Shareholders of record on Friday, November 17th were issued a $0.045 dividend. This represents a $0.18 annualized dividend and a yield of 0.29%. The ex-dividend date was Thursday, November 16th. Cognex’s payout ratio is currently 13.28%.
CGNX has been the subject of several recent research reports. Zacks Investment Research upgraded Cognex from a “hold” rating to a “buy” rating and set a $69.00 price target for the company in a research report on Wednesday, November 1st. Canaccord Genuity lifted their price target on Cognex from $47.50 to $60.00 and gave the company a “hold” rating in a research report on Tuesday, October 31st. Robert W. Baird lifted their price target on Cognex from $50.00 to $62.00 and gave the company a “neutral” rating in a research report on Tuesday, October 31st. Wolfe Research upgraded Cognex from a “market perform” rating to an “outperform” rating in a research report on Monday, August 14th. Finally, Cowen reissued an “outperform” rating and issued a $67.50 price objective (up from $50.00) on shares of Cognex in a report on Tuesday, August 8th. One investment analyst has rated the stock with a sell rating, three have given a hold rating, six have given a buy rating and one has assigned a strong buy rating to the company. Cognex currently has a consensus rating of “Buy” and an average price target of $56.86.
In other Cognex news, Director Jeffrey Benjamin Miller sold 3,750 shares of the firm’s stock in a transaction that occurred on Monday, November 6th. The stock was sold at an average price of $134.48, for a total value of $504,300.00. Following the sale, the director now directly owns 3,750 shares of the company’s stock, valued at $504,300. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Patrick Alias sold 5,000 shares of the firm’s stock in a transaction that occurred on Tuesday, September 12th. The shares were sold at an average price of $111.31, for a total value of $556,550.00. Following the completion of the sale, the director now directly owns 5,000 shares in the company, valued at $556,550. The disclosure for this sale can be found here. Over the last three months, insiders sold 148,750 shares of company stock worth $19,097,525. 5.60% of the stock is owned by corporate insiders.
COPYRIGHT VIOLATION WARNING: This piece of content was originally posted by The Ledger Gazette and is the property of of The Ledger Gazette. If you are accessing this piece of content on another site, it was illegally stolen and republished in violation of US & international copyright & trademark law. The legal version of this piece of content can be read at https://ledgergazette.com/2017/12/06/cognex-co-cgnx-shares-bought-by-temasek-holdings-private-ltd.html.
Cognex Corporation (Cognex) is a provider of machine vision products that capture and analyze visual information in order to automate tasks, primarily in manufacturing processes, where vision is required. The Company operates through the machine vision technology segment. The Company’s machine vision products are used to automate the manufacture and tracking of discrete items, such as mobile phones, aspirin bottles and automobile tires, by locating, identifying, inspecting and measuring them during the manufacturing or distribution process.
Want to see what other hedge funds are holding CGNX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cognex Co. (NASDAQ:CGNX).
Receive News & Ratings for Cognex Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cognex Co. and related companies with MarketBeat.com's FREE daily email newsletter.